The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Arterial calcification: A review of mechanisms, animal models, and the prospects for therapy
Abstract
The causes of arterial calcification are beginning to be elucidated. Macrophages, mast cells, and smooth muscle cells are the primary cells implicated in this process. The roles of a variety of bone‐related proteins including bone morphogenetic protein‐2 (BMP‐2), matrix Gla protein (MGP), osteoprotegerin (OPG), osteopontin, and osteonectin in regulating arterial calcification are reviewed. Animals lacking MGP, OPG, smad6, carbonic anhydrase isoenzyme II, fibrillin‐1, and klotho gene product develop varying extents of arterial calcification. Hyperlipidemia, vitamin D, nicotine, and warfarin, alone or in various combinations, produce arterial calcification in animal models. MGP has recently been discovered to be an inhibitor of bone morphogenetic protein‐2, the principal osteogenic growth factor. Many of the forces that induce arterial calcification may act by disrupting the essential post‐translational modification of MGP, allowing BMP‐2 to induce mineralization. MGP requires gamma‐carboxylation before it is functional, and this process uses vitamin K as an essential cofactor. Vitamin K deficiency, drugs that act as vitamin K antagonists, and oxidant stress are forces that could prevent the formation of GLA residues on MGP. The potential role of arterial apoptosis in calcification is discussed. Potential therapeutic options to limit the rate of arterial calcification are summarized. © 2001 John Wiley & Sons, Inc. Med Res Rev, 21, No. 4, 274–301, 2001
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 1×
“Mice lacking OPG-L lack osteoclasts and develop severe osteopetrosis.(74) Transgenic mice that overexpress OPG and those lacking RANK also have defective osteoclastogenesis and an osteopetrosis phenotype.”
BackgroundNegative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119
Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., & Stern, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118175 · Cited by 896
Ross, F. P., Chappel, J., Alvarez, J. I., Sander, D., Butler, W. T., Farach-Carson, M. C., Mintz, K. A., Robey, P. G., Teitelbaum, S. L., & Cheresh, D. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98430-9 · Cited by 537
Cited by
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
Hu, M. C., Shi, M., Zhang, J., Quiñones, H., Griffith, C., Kuro-o, M., & Moe, O. W. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121311 · Cited by 926
Pathophysiology of Vascular Calcification in Chronic Kidney Disease
Moe, S. M., & Chen, N. X. (2004) · Circulation Research · doi:10.1161/01.res.0000141775.67189.98 · Cited by 502
Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin
Collin-Osdoby, P. (2004) · Circulation Research · doi:10.1161/01.res.0000149165.99974.12 · Cited by 473
Osteoprotegerin Deficiency and Juvenile Paget's Disease
Whyte, M. P., Obrecht, S. E., Finnegan, P. M., Jones, J. L., Podgornik, M. N., McAlister, W. H., & Mumm, S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013096 · Cited by 445
Osteoporosis, inflammation and ageing
Ginaldi, L., Di Benedetto, M. C., & De Martinis, M. (2005) · Immunity & Ageing · doi:10.1186/1742-4933-2-14 · Cited by 412
Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease
Amann, K. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02120508 · Cited by 385
Vascular calcification in chronic kidney disease: different bricks in the wall?
Vervloet, M., & Cozzolino, M. (2017) · Kidney International · doi:10.1016/j.kint.2016.09.024 · Cited by 265
DAO, H., ESSALIHI, R., BOUVET, C., & MOREAU, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.012 · Cited by 258
Sabbagh, Y., Graciolli, F. G., O'Brien, S., Tang, W., dos Reis, L. M., Ryan, S., Phillips, L., Boulanger, J., Song, W., Bracken, C., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1630 · Cited by 254
Serum levels of osteoprotegerin increase with age in a healthy adult population.
Kudlacek, S., Schneider, B., Woloszczuk, W., Pietschmann, P., & Willvonseder, R. (2003) · Bone · doi:10.1016/s8756-3282(03)00090-5 · Cited by 187
Paget’s disease of bone and genetic disorders of RANKL/OPG/RANK/NF-κB signaling.
WHYTE, M. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.016 · Cited by 95
Pioglitazone attenuates valvular calcification induced by hypercholesterolemia
Chu, Y., Lund, D. D., Weiss, R. M., Brooks, R. M., Doshi, H., Hajj, G. P., Sigmund, C. D., & Heistad, D. D. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300794 · Cited by 49
Elastolytic activity of cysteine cathepsins K, S, and V promotes vascular calcification
Andrault, P.-M., Panwar, P., Mackenzie, N. C. W., & Brömme, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-45918-1 · Cited by 43
Tobacco smoking and subgingival dental calculus
Bergström, J. (2005) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2004.00638.x · Cited by 37
Metadata
- Authors
- Wallin, R., Wajih, N., Greenwood, G. T., & Sane, D. C.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2001-06-12
- Volume
- 21
- Issue
- 4
- Pages
- 274-301
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W1973653270
- Cited by
- 235
- References
- 7
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.